Literature DB >> 33905471

Depression Symptoms in Patients with Diabetic Peripheral Neuropathy.

Rahab Marhoon Alghafri1, Alfred Gatt1, Cynthia Formosa1.   

Abstract

AIM: The study aimed to investigate the possible relationship between diabetic peripheral neuropathy (DPN) and the development of depressive symptoms in patients with type 2 diabetes mellitus (T2D).
METHODS: A comparative non-experimental study was conducted. Ninety-five T2D individuals aged 65 years and more were recruited. The sample was divided into two groups: 50 participants with T2D and without DPN and 45 participants with T2D and DPN. The Patient Health Questionnaire 9 (PHQ-9) was used to collect information about low mood and depression symptoms in the subjects recruited.
RESULTS: Participants with DPN recorded higher scores on PHQ-9 than those with T2D only. The mean PHQ-9 score for the DPN group (6.09) was significantly higher than that for the T2D only group (2.24) (p < 0.001). Participants with DPN were more likely to have mild to moderate or moderately severe low mood and depression symptoms than T2D only participants who exhibited minimal to no low mood and depressive symptoms.
CONCLUSIONS: The association between DPN and depression is confirmed by this study, with significant depressive symptoms found in patients with neuropathy when compared to diabetes patients with no neurological complications. It is therefore important that discomfort and emotional problems caused by DPN should be taken seriously and addressed closely in the management of DPN in order to prevent depression. Also, a change in screening practices to identify patients with diabetes and depressive symptoms is required.

Entities:  

Mesh:

Year:  2020        PMID: 33905471      PMCID: PMC9380089          DOI: 10.1900/RDS.2020.16.35

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  18 in total

1.  Standards of medical care in diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

Review 2.  Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators.

Authors:  Rakesh Jain; Shailesh Jain; Charles L Raison; Vladimir Maletic
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 4.  Depression and public health: an overview.

Authors:  Paolo Cassano; Maurizio Fava
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

Review 5.  Depression in diabetic patients: the relationship between mood and glycemic control.

Authors:  Patrick J Lustman; Ray E Clouse
Journal:  J Diabetes Complications       Date:  2005 Mar-Apr       Impact factor: 2.852

6.  Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care.

Authors:  Isobel M Cameron; John R Crawford; Kenneth Lawton; Ian C Reid
Journal:  Br J Gen Pract       Date:  2008-01       Impact factor: 5.386

7.  Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study.

Authors:  Wayne J Katon; Elizabeth H B Lin; Lisa H Williams; Paul Ciechanowski; Susan R Heckbert; Evette Ludman; Carolyn Rutter; Paul K Crane; Malia Oliver; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2010-01-28       Impact factor: 5.128

8.  Utility and limitations of PHQ-9 in a clinic specializing in psychiatric care.

Authors:  Takeshi Inoue; Teruaki Tanaka; Shin Nakagawa; Yasuya Nakato; Rie Kameyama; Shuken Boku; Hiroyuki Toda; Tsugiko Kurita; Tsukasa Koyama
Journal:  BMC Psychiatry       Date:  2012-07-03       Impact factor: 3.630

9.  Cross-national epidemiology of DSM-IV major depressive episode.

Authors:  Evelyn Bromet; Laura Helena Andrade; Irving Hwang; Nancy A Sampson; Jordi Alonso; Giovanni de Girolamo; Ron de Graaf; Koen Demyttenaere; Chiyi Hu; Noboru Iwata; Aimee N Karam; Jagdish Kaur; Stanislav Kostyuchenko; Jean-Pierre Lépine; Daphna Levinson; Herbert Matschinger; Maria Elena Medina Mora; Mark Oakley Browne; Jose Posada-Villa; Maria Carmen Viana; David R Williams; Ronald C Kessler
Journal:  BMC Med       Date:  2011-07-26       Impact factor: 8.775

View more
  2 in total

1.  A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain.

Authors:  Emily Pickering; Elizabeth L Steels; Kathryn J Steadman; Amanda Rao; Luis Vitetta
Journal:  Inflammopharmacology       Date:  2022-09-04       Impact factor: 5.093

Review 2.  Diabetic Peripheral Neuropathy and Depression: Dancing with Wolves? - Mini-Review and Commentary on Alghafri et al. "Screening for depressive symptoms amongst patients with diabetic peripheral neuropathy".

Authors:  Prashanth R J Vas; Nikolaos Papanas
Journal:  Rev Diabet Stud       Date:  2021-05-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.